What is the size of the Global Serological Test for Influenza Disease Diagnostics Market?

In 2022, the Global Serological Test for Influenza Disease Market was valued at $0.8 Billion and is projected to reach a market size of $1.41 Billion by 2030. Over the forecast period of 2023-2030, market is projected to grow at a CAGR of 7.3%.

Which country is most dominating in the North American region for the Global Serological Test for Influenza Disease Diagnostics Market?

USA is the most dominating country in the North American region for the Global Serological Test for Influenza Disease Diagnostics Market.

Who are the leading players in the Global Serological Test for Influenza Disease Diagnostics Market?

Hologic, Inc., bioMérieux SA, Quidel Corporation, Becton, Dickinson and Company, Meridian Bioscience, GenMark Diagnostics, Inc., Luminex Corporation, Tecan Trading AG, DiaSorin SA, altona Diagnostics GmbH, SEKISUI Diagnostics, SA Scientific Ltd., Coris BioConcept SPRL, ELITech Group, Mast Group Ltd., Genome Diagnostics, Pvt. Ltd.

Serological Test for Influenza Disease Diagnostics Market | Size, Share, Growth

Q: What is the Global Serological Test for Influenza Disease Diagnostics Market Drivers?

The Global Serological Test for Influenza Disease Diagnostics Market drivers are an increase in the number of influenza virus patients and another technological advancement.